These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetics of human arterial hypertension. Naber CK; Siffert W Minerva Med; 2004 Oct; 95(5):347-56. PubMed ID: 15467511 [TBL] [Abstract][Full Text] [Related]
3. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension. Moretti JL; Burke SL; Evans RG; Lambert GW; Head GA J Hypertens; 2009 Sep; 27(9):1838-48. PubMed ID: 19512943 [TBL] [Abstract][Full Text] [Related]
4. [Hypertension in postmenopausal women --selected pathomechanisms]. Pośnik-Urbańska A; Kawecka-Jaszcz K Przegl Lek; 2006; 63(12):1313-7. PubMed ID: 17642147 [TBL] [Abstract][Full Text] [Related]
5. Essential hypertension: is there a role for inflammatory mechanisms? Androulakis ES; Tousoulis D; Papageorgiou N; Tsioufis C; Kallikazaros I; Stefanadis C Cardiol Rev; 2009; 17(5):216-21. PubMed ID: 19690472 [TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor activation in obesity hypertension. Nagase M; Fujita T Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418 [TBL] [Abstract][Full Text] [Related]
7. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Grassi G Hypertens Res; 2006 Nov; 29(11):839-47. PubMed ID: 17345783 [TBL] [Abstract][Full Text] [Related]
8. Role of the renin-angiotensin system in vascular inflammation. Marchesi C; Paradis P; Schiffrin EL Trends Pharmacol Sci; 2008 Jul; 29(7):367-74. PubMed ID: 18579222 [TBL] [Abstract][Full Text] [Related]
9. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. Galderisi M; de Divitiis O J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954 [TBL] [Abstract][Full Text] [Related]
10. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats. Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930 [TBL] [Abstract][Full Text] [Related]
11. [The autonomic nervous system and hypertension: quid novi?]. Elghozi JL; Herpin D Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1381-6. PubMed ID: 11190284 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling. Madeddu P; Emanueli C; El-Dahr S Nat Clin Pract Nephrol; 2007 Apr; 3(4):208-21. PubMed ID: 17389890 [TBL] [Abstract][Full Text] [Related]
13. [Contribution of rennin-angiotensin-aldosterone system genes and NO synthase gene to the development of arterial hypertension]. Savinetskaia GA; Golubeva AA; Pogoda TV; Generozov EV Klin Med (Mosk); 2008; 86(8):12-7. PubMed ID: 18819340 [TBL] [Abstract][Full Text] [Related]
14. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure. Borghi C; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E J Hypertens; 2007 Oct; 25(10):2051-7. PubMed ID: 17885547 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension. Georgescu A; Popov D; Dragan E; Dragomir E; Badila E Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521 [TBL] [Abstract][Full Text] [Related]